Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

Recruiting

3 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
- 2-((4S)-6-(4-Chlorophenyl)-1-Methyl-4H-Benzo[C]Isoxazolo[4,5-E]Azepin-4-Yl)Acetamide Monohydrate
- Ruxolitinib
+3
Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

Recruiting

4 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Safety and Effectiveness of Navtemadlin and Ruxolitinib for Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Recruiting

1 1 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
- Navtemadlin
- Ruxolitinib
Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

Recruiting

3 1 1 1
Investigated Drugs:
- Luspatercept
+2
Study on Tasquinimod for Patients with Myelofibrosis Who Are Refractory or Intolerant to JAK2 Inhibitors

Recruiting

1 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
- Tasquinimod
Study of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis

Not recruiting

2 1 1 1
Investigated Diseases:
- Primary myelofibrosis
Investigated Drugs:
- Momelotinib Dihydrochloride Monohydrate
- Luspatercept
Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Not recruiting

4 1 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
+7
Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Not recruiting

3 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
- Luspatercept
- Sodium Chloride
+6
Study of Fedratinib and Nivolumab for Patients with Myelofibrosis Resistant to JAK-inhibitor Treatment

Not recruiting

2 1 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
- Fedratinib
- Nivolumab
Study of Selinexor for Patients with Previously Treated Myelofibrosis

Not recruiting

2 1 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
- Selinexor

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies